Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts
- PMID: 11079531
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts
Abstract
Intrastriatal transplantation of dopaminergic neurones aims to repair the selective loss of nigrostriatal projections and the consequent dysfunction of striatocortical circuitries in Parkinson's disease (PD). Here, we have studied the effects of bilateral human embryonic dopaminergic grafts on the movement-related activation of frontal cortical areas in 4 PD patients using H2 15O positron emission tomography and a joystick movement task. At 6.5 months after transplantation, mean striatal dopamine storage capacity as measured by 18F-dopa positron emission tomography was already significantly elevated in these patients. This was associated with a modest clinical improvement on the Unified Parkinson's Disease Rating Scale, whereas the impaired cortical activation was unchanged. At 18 months after surgery, there was further significant clinical improvement in the absence of any additional increase in striatal 18F-dopa uptake. Rostral supplementary motor and dorsal prefrontal cortical activation during performance of joystick movements had significantly improved, however. Our data suggest that the function of the graft goes beyond that of a simple dopamine delivery system and that functional integration of the grafted neurones within the host brain is necessary to produce substantial clinical recovery in PD.
Similar articles
-
The effects of surgical treatment of Parkinson's disease on brain function: PET findings.Neurology. 2000;55(12 Suppl 6):S52-9. Neurology. 2000. PMID: 11188976 Review.
-
Motor disturbance and brain functional imaging in Parkinson's disease.Eur Neurol. 1997;38 Suppl 2:26-32. doi: 10.1159/000113473. Eur Neurol. 1997. PMID: 9387800 Review.
-
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.Ann Neurol. 1997 Jul;42(1):95-107. doi: 10.1002/ana.410420115. Ann Neurol. 1997. PMID: 9225690
-
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.N Engl J Med. 1995 Apr 27;332(17):1118-24. doi: 10.1056/NEJM199504273321702. N Engl J Med. 1995. PMID: 7700284
-
Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease.J Neuropsychiatry Clin Neurosci. 1995 Spring;7(2):176-9. doi: 10.1176/jnp.7.2.176. J Neuropsychiatry Clin Neurosci. 1995. PMID: 7626960
Cited by
-
Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson's Disease.Cell Transplant. 2024 Jan-Dec;33:9636897241246355. doi: 10.1177/09636897241246355. Cell Transplant. 2024. PMID: 38634440 Free PMC article. Review.
-
Dopaminergic Cell Replacement for Parkinson's Disease: Addressing the Intracranial Delivery Hurdle.J Parkinsons Dis. 2024;14(3):415-435. doi: 10.3233/JPD-230328. J Parkinsons Dis. 2024. PMID: 38457149 Free PMC article. Review.
-
Cell-therapy for Parkinson's disease: a systematic review and meta-analysis.J Transl Med. 2023 Sep 7;21(1):601. doi: 10.1186/s12967-023-04484-x. J Transl Med. 2023. PMID: 37679754 Free PMC article.
-
Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.Theranostics. 2023 Apr 29;13(8):2673-2692. doi: 10.7150/thno.80271. eCollection 2023. Theranostics. 2023. PMID: 37215566 Free PMC article.
-
Current Status of Stem Cell-Derived Therapies for Parkinson's Disease: From Cell Assessment and Imaging Modalities to Clinical Trials.Front Neurosci. 2020 Oct 16;14:558532. doi: 10.3389/fnins.2020.558532. eCollection 2020. Front Neurosci. 2020. PMID: 33177975 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical